Glycated haemoglobin (HbA1c) in mid-pregnancy and perinatal outcomes
Open Access
- 5 January 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 51 (3) , 759-768
Abstract
Background: Maternal diabetes is a well-known risk factor for pregnancy complications. Possible links between long-term maternal blood sugar in the normal range and pregnancy complications are less well described. Methods: We assayed glycated haemoglobin (HbA1c) in blood samples collected around the 18th week of pregnancy for 2937 singleton pregnancies in the Norwegian Mother, Father and Child Cohort Study (2000–09). Perinatal outcomes (gestational length, birthweight, birth length and head circumference, large-for-gestational age, small-for-gestational age, congenital malformations, preterm delivery and preeclampsia) were obtained from medical records. We tested associations using linear and log-binomial regression, adjusting for maternal age, body mass index (BMI) and smoking. Results: Size at birth increased modestly but linearly with HbA1c. Birthweight rose 0.10 standard deviations [95% confidence interval (CI): 0.03, 0.16], for each 5-mmol/mol unit increase in HbA1c, corresponding to about 40 g at 40 weeks of gestation. Large-for-gestational age rose 23% (95% CI: 1%, 50%) per five-unit increase. Other pregnancy complications increased in non-linear fashion, with strongest associations within the top quartile of HbA1c (>35 mmol/mol or >5.4%). Per unit HbA1c within the top quartile, preterm delivery increased by 14% (95% CI: 1%, 31%), preeclampsia increased by 20% (95% CI: 5%, 37%) and gestational duration decreased by 0.7 days (95% CI: −1.0, −0.3). Conclusions: Among women with no recorded diabetes, higher HbA1c levels at 18 gestational weeks were associated with important perinatal outcomes independent of mother’s age, smoking or BMI.Keywords
Funding Information
- The Norwegian Mother
- Father and Child Cohort
- Norwegian Ministry of Health and Care Services and the Ministry of Education and Research
- Norwegian Research Council’s Centres of Excellence Funding Scheme (262700)
- Medical Research Council Integrative Epidemiology Unit at the University of Bristol
- UK MRC (MC_UU_00011/3 and MC_UU_00011/6)
- National Institute of Environmental Health Sciences
- National Institutes of Health
This publication has 37 references indexed in Scilit:
- Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteriaBMC Pregnancy and Childbirth, 2012
- The Hyperglycemia and Adverse Pregnancy Outcome StudyDiabetes Care, 2012
- Hyperglycemia and Adverse Pregnancy Outcome (HAPO) StudyDiabetes Care, 2012
- Trimester-specific reference intervals for haemoglobin A1c (HbA1c) in pregnancyClinical Chemistry and Laboratory Medicine (CCLM), 2011
- Congenital anomalies in newborns of women with type 1 diabetes: nationwide population‐based study in Norway, 1999–2004Acta Obstetricia et Gynecologica Scandinavica, 2010
- International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in PregnancyDiabetes Care, 2010
- International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in PregnancyDiabetes Care, 2010
- Self‐selection and bias in a large prospective pregnancy cohort in NorwayPaediatric and Perinatal Epidemiology, 2009
- Hyperglycemia and Adverse Pregnancy Outcome (HAPO) StudyDiabetes, 2009
- Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decadeDiabetic Medicine, 2005